Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT00002658
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* De novo or secondary acute myeloid leukemia of any morphologic type
* Acute promyelocytic leukemia also entered on MRC ATRA trial
* No blastic transformation of chronic myeloid leukemia
PATIENT CHARACTERISTICS:
Age:
* 15 to physiologic 59
* Patients for whom intensive therapy is considered inappropriate may be entered on protocol MRC-LEUK-AML11 or its successor
Performance status:
* Any status
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* No concurrent active malignancy
* Not pregnant or nursing
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* No prior cytotoxic chemotherapy for leukemia
Endocrine therapy
* Not specified
Radiotherapy
* Not specified
Surgery
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT00002658
Study Brief:
Protocol Section:
NCT00002658